Lotus Apothecary

Project Alleviate

 
 
Products & Services


Company products

Lotus Apothecary Project Alleviate combines modern biotechnology, molecular biology including holistic milieu therapy, and ancient biological medicine. Lotus Apothecary Project Alleviate develops their primary products based on viral vaccines and peptides. Additionally Lotus Apothecary Project Alleviate will offer custom development and custom manufacturing services both to pharmaceutical and medical institutions.

The major input comes from Dr. Pearl Laperla, USA, founder and CEO of Lotus Apothecary Project Alleviate. This unique constellation results from the incorporation of the interesting theories of Antoine Bechamp(1816-1908) and Professor Dr. Gunther Enderlein (1872-1968), and the knowledge of the ancient, natural medicine, particularly the Ayurvedic Medicine.

The major product lines and their potential fields of application within the manufacturing part of LAPA are shown in Fig. 1.

Fig. 1: Current product line of LAPA

LAPA Product Line
Indications
Immune Modulators Drug candidates deducted from inactivated viruses, Infections like hepatitis, herpes, malignant melanoma, Non-Hodgkin disease, prostate, mumps, lung, stomach, or colon cancer, etc.
Viral Vector Vaccines Immune infections like HIV
Modified Peptides (Lanthionines)

Lanthionine Bridged Peptides
Heavy pain treatment (to substitute Morphine)

Super Skin Non-healing wounds
Restores skin and tissue

 




 


 
 

Lotus Apothecary Project Alleviate; Head office (NV), Administration office (NV)